Mike Evers of Orthoworld estimates that orthopedic sales grew in the mid-single digits for the first quarter of 2022 and that the remaining challenges are manageable.

Content republished with permission from ORTHOWORLD® Inc.

Mike Evers of Orthoworld discusses how the orthopedic market finds itself in familiar territory in early 2022, with COVID infections surging to record levels. While we await fourth-quarter and full-year results from orthopedic companies, we'll summarize below our expectations and questions for the market as it enters the third year of disruption from the pandemic.

Content republished with permission from ORTHOWORLD® Inc.